Skip Navigation

Cover Image
Other Issues:
Previous Next 		Contents: Volume 7, Suppl L : November 2005   [Index by Author] 
      Down Preface
      Down Articles
      Down Questions

 
 
Obesity management: The cardiovascular benefits Proceedings of a meeting held in Cannes, April 2005

This work was supported by an unrestricted educational grant from Abbott

Guest editors:
W. Philip T. James (UK)
F. Van de Werf (Belgium)
 


[Search ALL Issues]



To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Preface:Back

Francisco Fernández-Avilés
Preface
Eur Heart J Suppl 2005; 7: L1. [Extract] [Full Text] [PDF]  

Articles:Back

W. Philip T. James and Frans Van de Werf
Obesity management: the cardiovascular benefits
Eur Heart J Suppl 2005; 7: L3-L4. [Extract] [Full Text] [PDF]  

David A. Wood
Guidelines on cardiovascular risk assessment and management
Eur Heart J Suppl 2005; 7: L5-L10. [Abstract] [Full Text] [PDF]  

Leif R. Erhardt
Managing cardiovascular risk: reality vs. perception
Eur Heart J Suppl 2005; 7: L11-L15. [Abstract] [Full Text] [PDF]  

Eric Bruckert
Impact of lipid treatment on cardiovascular risk reduction: new therapeutic targets
Eur Heart J Suppl 2005; 7: L16-L20. [Abstract] [Full Text] [PDF]  

Luc F. Van Gaal, Ilse L. Mertens, and Dominique Ballaux
What is the relationship between risk factor reduction and degree of weight loss?
Eur Heart J Suppl 2005; 7: L21-L26. [Abstract] [Full Text] [PDF]  

Donna Ryan
Risks and benefits of weight loss: challenges to obesity research
Eur Heart J Suppl 2005; 7: L27-L31. [Abstract] [Full Text] [PDF]  

Nick Finer
Does pharmacologically induced weight loss improve cardiovascular outcome? Impact of anti-obesity agents on cardiovascular risk factors
Eur Heart J Suppl 2005; 7: L32-L38. [Abstract] [Full Text] [PDF]  

Arya M. Sharma
Does pharmacologically induced weight loss improve cardiovascular outcome? Sibutramine pharmacology and the cardiovascular system
Eur Heart J Suppl 2005; 7: L39-L43. [Abstract] [Full Text] [PDF]  

W. Philip T. James
The SCOUT study: risk-benefit profile of sibutramine in overweight high-risk cardiovascular patients
Eur Heart J Suppl 2005; 7: L44-L48. [Abstract] [Full Text] [PDF]  

Questions:Back

Questions
Eur Heart J Suppl 2005; 7: L49-L52. [Extract] [Full Text] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.